Ask AI
ProCE Banner Activity

Barriers to Access and Manufacturing Delays in CAR T-Cell Therapy 

Slideset

Downloadable slideset on the key barriers to access and manufacturing delays in CAR T-cell therapy for multiple myeloma, including patient eligibility, logistical challenges, and the importance of early referral and coordinated bridging strategies between treatment centers and community oncologists.

Released: December 09, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Target Audience

This activity has been designed to meet the educational needs of hematologists/oncologists and other healthcare professionals caring for patients with multiple myeloma who are likely to benefit from bridging therapy prior to CAR T-cell treatment. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the challenges of access to and manufacturing of CAR T-cell therapy and role of bridging therapeutic strategies in patients with multiple myeloma